ROYAL BANK OF CANADA - NEUBASE THERAPEUTICS INC ownership

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 59 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$030
-94.8%
0.00%
Q3 2022$0
-100.0%
576
-98.8%
0.00%
Q2 2022$51,000
-76.3%
48,497
-57.6%
0.00%
Q1 2022$215,000
+9.7%
114,473
+64.3%
0.00%
Q4 2021$196,000
+67.5%
69,682
+113.8%
0.00%
Q3 2021$117,000
-71.6%
32,585
-62.1%
0.00%
Q2 2021$412,000
+396.4%
85,955
+664.5%
0.00%
Q1 2021$83,000
+130.6%
11,244
+121.1%
0.00%
Q4 2020$36,000
+157.1%
5,086
+182.6%
0.00%
Q3 2020$14,000
-12.5%
1,8000.0%0.00%
Q2 2020$16,0001,8000.00%
Other shareholders
NEUBASE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CARNEGIE MELLON UNIVERSITY 46,970$40,8550.05%
View complete list of NEUBASE THERAPEUTICS INC shareholders